Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

This study has been completed.
Information provided by:
Medical University of South Carolina Identifier:
First received: July 8, 2005
Last updated: April 26, 2012
Last verified: April 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2008
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)